ImageneBio, Inc. (IMA)
NASDAQ: IMA · Real-Time Price · USD
5.63
-0.02 (-0.35%)
Jun 8, 2026, 4:00 PM EDT - Market closed

ImageneBio Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
6477472396451
Market Cap Growth
-63.03%104.11%-75.96%-78.62%-
Enterprise Value
-51.29-57.48213.45-145.1-56.72224.05
Last Close Price
5.636.9019.6823.6431.92150.48
PS Ratio
-96.4413.522.536.1814.56
PB Ratio
0.510.58-0.290.140.662.17
P/TBV Ratio
0.360.25-0.600.480.661.69
EV/Sales Ratio
--71.8560.99-15.84-3.637.23
EV/EBITDA Ratio
-1.21-1.950.81-
EV/EBIT Ratio
-1.19-1.920.80-
EV/FCF Ratio
-1.20-1.810.75-
Debt / Equity Ratio
0.000.01-0.160.040.030.02
Net Debt / Equity Ratio
-0.93-0.990.03-0.97-1.03-1.08
Net Debt / EBITDA Ratio
2.082.790.122.212.166.71
Net Debt / FCF Ratio
2.202.770.192.062.003.63
Asset Turnover
-0.010.030.050.070.15
Quick Ratio
17.6712.050.7012.357.308.54
Current Ratio
18.3912.490.7212.587.448.70
Return on Equity (ROE)
-35.15%-68.91%-43.47%-43.04%-38.76%-21.81%
Return on Assets (ROA)
-38.53%-56.93%-35.59%-41.50%-33.75%-16.40%
Return on Invested Capital (ROIC)
-349.52%-357.96%-256.14%-375.13%-264.42%-127.48%
Return on Capital Employed (ROCE)
-41.15%-68.99%-41.90%-45.90%-38.18%-18.93%
Buyback Yield / Dilution
98.35%0.00%-40.05%-15.33%-29.32%-911.88%
Total Shareholder Return
98.35%0.00%-40.05%-15.33%-29.32%-911.88%
SEC Filings: 10-K · 10-Q